| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 48 | 2024 | 3397 | 4.270 |
Why?
|
| Genetic Vectors | 41 | 2024 | 3396 | 3.520 |
Why?
|
| Lentivirus | 11 | 2024 | 508 | 3.090 |
Why?
|
| Anemia, Sickle Cell | 10 | 2024 | 1063 | 2.440 |
Why?
|
| rac GTP-Binding Proteins | 13 | 2017 | 162 | 2.430 |
Why?
|
| Adrenoleukodystrophy | 6 | 2024 | 143 | 2.370 |
Why?
|
| Fanconi Anemia | 12 | 2013 | 324 | 2.190 |
Why?
|
| Fetal Hemoglobin | 5 | 2022 | 345 | 1.860 |
Why?
|
| rho GTP-Binding Proteins | 6 | 2022 | 276 | 1.760 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 25 | 2024 | 5672 | 1.650 |
Why?
|
| Retroviridae | 15 | 2022 | 850 | 1.600 |
Why?
|
| p21-Activated Kinases | 3 | 2017 | 128 | 1.450 |
Why?
|
| Hematopoiesis | 12 | 2023 | 2050 | 1.380 |
Why?
|
| National Institutes of Health (U.S.) | 8 | 2010 | 793 | 1.240 |
Why?
|
| gamma-Globins | 5 | 2022 | 106 | 1.230 |
Why?
|
| Adenosine Deaminase | 9 | 2017 | 251 | 1.190 |
Why?
|
| Transduction, Genetic | 7 | 2024 | 903 | 1.170 |
Why?
|
| Hematology | 4 | 2017 | 243 | 1.050 |
Why?
|
| Anemia, Aplastic | 3 | 2020 | 230 | 1.020 |
Why?
|
| Severe Combined Immunodeficiency | 4 | 2017 | 227 | 0.980 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 2018 | 91 | 0.960 |
Why?
|
| beta-Thalassemia | 3 | 2020 | 236 | 0.910 |
Why?
|
| Biological Assay | 2 | 2016 | 626 | 0.830 |
Why?
|
| Gene Transfer Techniques | 11 | 2014 | 1206 | 0.820 |
Why?
|
| Hemoglobinopathies | 1 | 2022 | 99 | 0.760 |
Why?
|
| Antigens, CD34 | 9 | 2024 | 658 | 0.750 |
Why?
|
| Transcription Factors | 9 | 2022 | 12130 | 0.730 |
Why?
|
| RNA Interference | 3 | 2020 | 2832 | 0.730 |
Why?
|
| cdc42 GTP-Binding Protein | 3 | 2020 | 187 | 0.730 |
Why?
|
| Wiskott-Aldrich Syndrome | 3 | 2023 | 131 | 0.710 |
Why?
|
| Advisory Committees | 3 | 2009 | 787 | 0.680 |
Why?
|
| Awards and Prizes | 2 | 2017 | 360 | 0.670 |
Why?
|
| Leukocyte-Adhesion Deficiency Syndrome | 2 | 2010 | 21 | 0.650 |
Why?
|
| Dependovirus | 4 | 2008 | 718 | 0.640 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2021 | 621 | 0.610 |
Why?
|
| Cytokine Receptor gp130 | 1 | 2018 | 66 | 0.600 |
Why?
|
| Flow Cytometry | 5 | 2016 | 5870 | 0.600 |
Why?
|
| Interleukin-11 | 1 | 2018 | 58 | 0.590 |
Why?
|
| Cell Movement | 9 | 2016 | 5205 | 0.570 |
Why?
|
| Mice | 57 | 2024 | 81539 | 0.570 |
Why?
|
| Repressor Proteins | 5 | 2022 | 2986 | 0.570 |
Why?
|
| Lymphoma | 4 | 2022 | 1901 | 0.550 |
Why?
|
| Cytoskeleton | 3 | 2016 | 1170 | 0.540 |
Why?
|
| Animals | 73 | 2024 | 168475 | 0.540 |
Why?
|
| Bone Marrow Transplantation | 5 | 2020 | 2693 | 0.520 |
Why?
|
| Myeloid Cells | 1 | 2020 | 823 | 0.500 |
Why?
|
| RNA, Small Interfering | 5 | 2020 | 3430 | 0.490 |
Why?
|
| Transgenes | 4 | 2014 | 1010 | 0.490 |
Why?
|
| Neutrophils | 4 | 2018 | 3767 | 0.490 |
Why?
|
| Research Support as Topic | 4 | 2008 | 697 | 0.480 |
Why?
|
| Neuropeptides | 6 | 2011 | 944 | 0.480 |
Why?
|
| Stem Cells | 4 | 2018 | 3524 | 0.470 |
Why?
|
| Fanconi Anemia Complementation Group A Protein | 3 | 2012 | 50 | 0.470 |
Why?
|
| Mutagenesis, Insertional | 7 | 2007 | 656 | 0.470 |
Why?
|
| Wiskott-Aldrich Syndrome Protein | 2 | 2023 | 161 | 0.470 |
Why?
|
| Bone Marrow | 10 | 2016 | 2911 | 0.470 |
Why?
|
| Immunosuppressive Agents | 2 | 2020 | 4176 | 0.470 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2017 | 563 | 0.460 |
Why?
|
| Zinc Fingers | 1 | 2016 | 579 | 0.460 |
Why?
|
| X-Linked Combined Immunodeficiency Diseases | 2 | 2014 | 24 | 0.450 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2013 | 15 | 0.450 |
Why?
|
| Medical Oncology | 3 | 2017 | 2321 | 0.440 |
Why?
|
| Mice, Knockout | 17 | 2022 | 14417 | 0.430 |
Why?
|
| Gene Knockdown Techniques | 5 | 2020 | 1612 | 0.430 |
Why?
|
| Leukodystrophy, Metachromatic | 1 | 2013 | 44 | 0.430 |
Why?
|
| Clinical Trials as Topic | 10 | 2017 | 8002 | 0.430 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2017 | 547 | 0.430 |
Why?
|
| Common Variable Immunodeficiency | 1 | 2014 | 101 | 0.420 |
Why?
|
| Mastocytosis, Systemic | 1 | 2014 | 103 | 0.410 |
Why?
|
| Cell Lineage | 5 | 2016 | 2557 | 0.400 |
Why?
|
| Chemokines | 1 | 2016 | 959 | 0.400 |
Why?
|
| Stem Cell Niche | 2 | 2016 | 345 | 0.400 |
Why?
|
| Pluripotent Stem Cells | 2 | 2009 | 799 | 0.400 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 3 | 2007 | 83 | 0.400 |
Why?
|
| Proto-Oncogene Proteins c-kit | 2 | 2014 | 727 | 0.390 |
Why?
|
| Humans | 114 | 2024 | 761596 | 0.380 |
Why?
|
| Cell Communication | 3 | 2016 | 1657 | 0.370 |
Why?
|
| Carrier Proteins | 6 | 2022 | 4937 | 0.370 |
Why?
|
| rac1 GTP-Binding Protein | 8 | 2011 | 242 | 0.360 |
Why?
|
| Financing, Organized | 2 | 2010 | 204 | 0.360 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2012 | 1860 | 0.350 |
Why?
|
| Neoplastic Stem Cells | 3 | 2014 | 1351 | 0.340 |
Why?
|
| Mice, SCID | 5 | 2016 | 2626 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 22 | 2018 | 22174 | 0.340 |
Why?
|
| Congresses as Topic | 4 | 2014 | 803 | 0.340 |
Why?
|
| Gene Silencing | 2 | 2015 | 1509 | 0.330 |
Why?
|
| Bone Marrow Cells | 7 | 2014 | 2417 | 0.330 |
Why?
|
| Embryo Research | 1 | 2009 | 38 | 0.330 |
Why?
|
| Stem Cell Factor | 3 | 2011 | 195 | 0.330 |
Why?
|
| Education, Medical, Graduate | 2 | 2012 | 2373 | 0.320 |
Why?
|
| Nuclear Proteins | 4 | 2022 | 5799 | 0.320 |
Why?
|
| Signal Transduction | 11 | 2022 | 23447 | 0.310 |
Why?
|
| Mice, Inbred NOD | 5 | 2016 | 1827 | 0.310 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2008 | 234 | 0.310 |
Why?
|
| Cells, Cultured | 13 | 2018 | 18966 | 0.310 |
Why?
|
| Bone Development | 1 | 2011 | 472 | 0.310 |
Why?
|
| Spumavirus | 1 | 2008 | 17 | 0.310 |
Why?
|
| Transposases | 1 | 2008 | 104 | 0.300 |
Why?
|
| Academies and Institutes | 1 | 2010 | 318 | 0.300 |
Why?
|
| Patient Selection | 1 | 2020 | 4244 | 0.300 |
Why?
|
| Lysosomes | 1 | 2013 | 924 | 0.300 |
Why?
|
| Wnt Proteins | 2 | 2011 | 718 | 0.300 |
Why?
|
| Pediatrics | 3 | 2012 | 3589 | 0.300 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2007 | 53 | 0.290 |
Why?
|
| Societies, Medical | 3 | 2010 | 3905 | 0.290 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 3 | 2018 | 225 | 0.290 |
Why?
|
| Cancer Care Facilities | 1 | 2010 | 422 | 0.290 |
Why?
|
| Dog Diseases | 1 | 2008 | 141 | 0.290 |
Why?
|
| Sirolimus | 1 | 2014 | 1533 | 0.280 |
Why?
|
| Publications | 1 | 2009 | 194 | 0.280 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2008 | 686 | 0.280 |
Why?
|
| DNA Modification Methylases | 1 | 2007 | 210 | 0.270 |
Why?
|
| Health Care Surveys | 1 | 2013 | 2426 | 0.270 |
Why?
|
| Gammaretrovirus | 2 | 2017 | 24 | 0.270 |
Why?
|
| Methenamine | 1 | 2005 | 5 | 0.260 |
Why?
|
| Oxymetazoline | 1 | 2005 | 5 | 0.260 |
Why?
|
| Osteoblasts | 1 | 2011 | 1143 | 0.260 |
Why?
|
| Hippurates | 1 | 2005 | 16 | 0.260 |
Why?
|
| Cell Separation | 2 | 2014 | 1720 | 0.260 |
Why?
|
| Nasal Decongestants | 1 | 2005 | 29 | 0.260 |
Why?
|
| Anti-Infective Agents, Urinary | 1 | 2005 | 28 | 0.260 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 2 | 2004 | 164 | 0.260 |
Why?
|
| Mandelic Acids | 1 | 2005 | 46 | 0.260 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2007 | 431 | 0.250 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2014 | 4514 | 0.250 |
Why?
|
| Transfection | 9 | 2014 | 5774 | 0.250 |
Why?
|
| DNA Repair Enzymes | 1 | 2007 | 346 | 0.250 |
Why?
|
| Triamcinolone Acetonide | 1 | 2005 | 100 | 0.250 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2005 | 97 | 0.250 |
Why?
|
| Nucleoside Deaminases | 4 | 1989 | 58 | 0.240 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2005 | 167 | 0.240 |
Why?
|
| Codon, Nonsense | 1 | 2006 | 285 | 0.240 |
Why?
|
| DNA Transposable Elements | 1 | 2008 | 755 | 0.240 |
Why?
|
| Blotting, Western | 4 | 2014 | 5035 | 0.240 |
Why?
|
| Mice, Transgenic | 11 | 2022 | 9542 | 0.230 |
Why?
|
| Transplantation, Autologous | 2 | 2020 | 2115 | 0.230 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2007 | 651 | 0.230 |
Why?
|
| Retinal Degeneration | 1 | 2008 | 413 | 0.230 |
Why?
|
| Myelodysplastic Syndromes | 4 | 2024 | 1394 | 0.220 |
Why?
|
| Leukemia, T-Cell | 1 | 2004 | 101 | 0.220 |
Why?
|
| Jurkat Cells | 2 | 2016 | 740 | 0.220 |
Why?
|
| Hospitals, Pediatric | 2 | 2010 | 1860 | 0.220 |
Why?
|
| Gene Expression | 8 | 2017 | 7581 | 0.220 |
Why?
|
| Leukemia | 2 | 2016 | 1522 | 0.210 |
Why?
|
| Genes, Lethal | 1 | 2003 | 223 | 0.210 |
Why?
|
| Guidelines as Topic | 1 | 2009 | 1386 | 0.210 |
Why?
|
| History, 20th Century | 3 | 2017 | 2767 | 0.210 |
Why?
|
| T-Lymphocytes | 4 | 2016 | 10194 | 0.210 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2016 | 4352 | 0.210 |
Why?
|
| Hemoglobins, Abnormal | 1 | 2022 | 119 | 0.200 |
Why?
|
| Mutagenesis | 1 | 2006 | 1232 | 0.200 |
Why?
|
| Indoles | 2 | 2024 | 1833 | 0.200 |
Why?
|
| Oncolytic Viruses | 1 | 2006 | 344 | 0.200 |
Why?
|
| Gene Duplication | 1 | 2003 | 314 | 0.200 |
Why?
|
| Embryonic Stem Cells | 1 | 2009 | 1263 | 0.200 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 1809 | 0.200 |
Why?
|
| Child | 14 | 2024 | 80158 | 0.200 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2005 | 494 | 0.200 |
Why?
|
| Fellowships and Scholarships | 1 | 2010 | 1117 | 0.190 |
Why?
|
| HIV | 1 | 2009 | 1582 | 0.190 |
Why?
|
| Cell Proliferation | 7 | 2018 | 10451 | 0.190 |
Why?
|
| Pyrimidines | 4 | 2024 | 3028 | 0.190 |
Why?
|
| Anemia, Hemolytic | 1 | 2022 | 162 | 0.190 |
Why?
|
| Hemoglobin, Sickle | 1 | 2021 | 113 | 0.190 |
Why?
|
| DNA-Binding Proteins | 4 | 2014 | 9610 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2022 | 191 | 0.190 |
Why?
|
| Myeloproliferative Disorders | 1 | 2007 | 613 | 0.190 |
Why?
|
| Eczema | 1 | 2023 | 246 | 0.180 |
Why?
|
| History, 21st Century | 2 | 2017 | 1567 | 0.180 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2012 | 1640 | 0.180 |
Why?
|
| Oncolytic Virotherapy | 1 | 2006 | 516 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2008 | 2805 | 0.180 |
Why?
|
| Herpesvirus 1, Human | 1 | 2006 | 753 | 0.180 |
Why?
|
| Phenotype | 8 | 2022 | 16592 | 0.170 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2009 | 2199 | 0.170 |
Why?
|
| Erythropoiesis | 3 | 2014 | 683 | 0.170 |
Why?
|
| Proto-Oncogenes | 3 | 2006 | 321 | 0.170 |
Why?
|
| Biomedical Research | 2 | 2005 | 3429 | 0.170 |
Why?
|
| Chemokine CXCL12 | 2 | 2012 | 454 | 0.170 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 2418 | 0.170 |
Why?
|
| Disease Models, Animal | 6 | 2022 | 18255 | 0.170 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2014 | 3615 | 0.160 |
Why?
|
| Protein Transport | 2 | 2016 | 1967 | 0.160 |
Why?
|
| MicroRNAs | 1 | 2015 | 3816 | 0.160 |
Why?
|
| Tumor Microenvironment | 1 | 2012 | 3878 | 0.160 |
Why?
|
| Apoptosis | 6 | 2018 | 9490 | 0.160 |
Why?
|
| Viral Proteins | 1 | 2006 | 1804 | 0.160 |
Why?
|
| Virus Replication | 2 | 2022 | 2435 | 0.160 |
Why?
|
| Reticulocytes | 2 | 2012 | 289 | 0.160 |
Why?
|
| Pilot Projects | 3 | 2020 | 8633 | 0.160 |
Why?
|
| Drug Approval | 1 | 2005 | 814 | 0.150 |
Why?
|
| Enzyme Activation | 2 | 2016 | 3597 | 0.150 |
Why?
|
| Gene Rearrangement | 1 | 2003 | 1125 | 0.150 |
Why?
|
| Genetic Engineering | 4 | 2007 | 933 | 0.150 |
Why?
|
| Adolescent | 11 | 2024 | 88326 | 0.150 |
Why?
|
| Primary Myelofibrosis | 1 | 2020 | 209 | 0.150 |
Why?
|
| Hematologic Neoplasms | 2 | 2024 | 1896 | 0.150 |
Why?
|
| Mutation | 10 | 2023 | 30053 | 0.150 |
Why?
|
| Down-Regulation | 2 | 2020 | 2919 | 0.150 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 2139 | 0.150 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2016 | 3605 | 0.150 |
Why?
|
| Blood Component Removal | 1 | 2018 | 132 | 0.140 |
Why?
|
| Heterocyclic Compounds | 1 | 2018 | 246 | 0.140 |
Why?
|
| Base Sequence | 6 | 2019 | 12441 | 0.140 |
Why?
|
| Warfarin | 2 | 2016 | 1483 | 0.140 |
Why?
|
| Exons | 1 | 2003 | 2391 | 0.140 |
Why?
|
| Retina | 1 | 2008 | 2659 | 0.140 |
Why?
|
| Cell Line | 5 | 2022 | 15601 | 0.140 |
Why?
|
| Combined Modality Therapy | 2 | 2020 | 8527 | 0.140 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 4111 | 0.140 |
Why?
|
| Child, Preschool | 7 | 2024 | 42232 | 0.140 |
Why?
|
| ras Proteins | 1 | 2022 | 1054 | 0.140 |
Why?
|
| Infant | 9 | 2022 | 36193 | 0.140 |
Why?
|
| United States | 13 | 2010 | 72340 | 0.140 |
Why?
|
| Consensus | 1 | 2006 | 3124 | 0.130 |
Why?
|
| Follow-Up Studies | 4 | 2024 | 39106 | 0.130 |
Why?
|
| Erythrocytes | 2 | 2016 | 2413 | 0.130 |
Why?
|
| Male | 24 | 2024 | 360846 | 0.130 |
Why?
|
| Neonatal Screening | 1 | 2020 | 597 | 0.130 |
Why?
|
| Cell Adhesion | 2 | 2016 | 3088 | 0.130 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2015 | 114 | 0.130 |
Why?
|
| Neoplasms | 5 | 2023 | 22173 | 0.130 |
Why?
|
| Chimerism | 1 | 2016 | 155 | 0.120 |
Why?
|
| Cell Shape | 1 | 2016 | 371 | 0.120 |
Why?
|
| Tissue Banks | 1 | 2016 | 184 | 0.120 |
Why?
|
| Gene Order | 1 | 2015 | 169 | 0.120 |
Why?
|
| Spleen | 3 | 2012 | 2295 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2005 | 2759 | 0.120 |
Why?
|
| Solutions | 2 | 2005 | 412 | 0.120 |
Why?
|
| Indicators and Reagents | 2 | 2005 | 462 | 0.120 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2017 | 629 | 0.120 |
Why?
|
| Erythroblasts | 2 | 2012 | 142 | 0.120 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1787 | 0.120 |
Why?
|
| Genes | 2 | 1989 | 1823 | 0.120 |
Why?
|
| Siblings | 2 | 2020 | 825 | 0.120 |
Why?
|
| Syndrome | 1 | 2020 | 3267 | 0.110 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2022 | 2827 | 0.110 |
Why?
|
| Prenylation | 1 | 2013 | 37 | 0.110 |
Why?
|
| Oxandrolone | 1 | 2013 | 24 | 0.110 |
Why?
|
| Erythroid Cells | 1 | 2015 | 238 | 0.110 |
Why?
|
| Prognosis | 3 | 2020 | 29629 | 0.110 |
Why?
|
| Polyethyleneimine | 1 | 2014 | 68 | 0.110 |
Why?
|
| Metalloproteins | 2 | 2004 | 101 | 0.110 |
Why?
|
| Research Personnel | 2 | 2010 | 588 | 0.110 |
Why?
|
| GATA1 Transcription Factor | 1 | 2014 | 296 | 0.110 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2013 | 94 | 0.100 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2016 | 178 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2014 | 517 | 0.100 |
Why?
|
| Calcium Phosphates | 1 | 2014 | 171 | 0.100 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1994 | 1058 | 0.100 |
Why?
|
| Niacinamide | 1 | 2014 | 413 | 0.100 |
Why?
|
| Metaphase | 1 | 2012 | 145 | 0.100 |
Why?
|
| Phagocytes | 2 | 2010 | 295 | 0.100 |
Why?
|
| Azacitidine | 1 | 2014 | 336 | 0.100 |
Why?
|
| Safety | 2 | 2007 | 1149 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2012 | 5882 | 0.100 |
Why?
|
| Chemokine CXCL13 | 1 | 2012 | 59 | 0.100 |
Why?
|
| Retinal Telangiectasis | 1 | 2012 | 25 | 0.100 |
Why?
|
| Embryoid Bodies | 1 | 2012 | 65 | 0.100 |
Why?
|
| Reference Standards | 2 | 2005 | 1003 | 0.100 |
Why?
|
| Antilymphocyte Serum | 1 | 2013 | 487 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2005 | 1541 | 0.100 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 983 | 0.100 |
Why?
|
| Dioxygenases | 1 | 2014 | 345 | 0.100 |
Why?
|
| Protein Stability | 1 | 2013 | 578 | 0.100 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 2 | 2014 | 86 | 0.100 |
Why?
|
| Leukemia, Biphenotypic, Acute | 1 | 2011 | 32 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2012 | 4142 | 0.100 |
Why?
|
| Aminoquinolines | 2 | 2011 | 107 | 0.100 |
Why?
|
| Nucleic Acid Conformation | 1 | 2015 | 902 | 0.100 |
Why?
|
| Cell Differentiation | 6 | 2012 | 11530 | 0.100 |
Why?
|
| Dyskeratosis Congenita | 1 | 2012 | 73 | 0.100 |
Why?
|
| Telomere-Binding Proteins | 1 | 2012 | 119 | 0.090 |
Why?
|
| Polycythemia Vera | 1 | 2013 | 161 | 0.090 |
Why?
|
| Actins | 2 | 2016 | 2050 | 0.090 |
Why?
|
| Protein Kinases | 1 | 2018 | 1608 | 0.090 |
Why?
|
| Protein Binding | 3 | 2016 | 9353 | 0.090 |
Why?
|
| Bone Marrow Diseases | 2 | 2013 | 233 | 0.090 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 931 | 0.090 |
Why?
|
| Gastric Mucosa | 1 | 2014 | 604 | 0.090 |
Why?
|
| Cyclosporine | 1 | 2013 | 778 | 0.090 |
Why?
|
| Microscopy, Video | 1 | 2011 | 241 | 0.090 |
Why?
|
| Anabolic Agents | 1 | 2013 | 256 | 0.090 |
Why?
|
| Granulomatous Disease, Chronic | 2 | 2006 | 173 | 0.090 |
Why?
|
| Erythroid Precursor Cells | 2 | 2019 | 211 | 0.090 |
Why?
|
| Histones | 2 | 2018 | 2580 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2017 | 6075 | 0.090 |
Why?
|
| Intermediate Filament Proteins | 1 | 2011 | 262 | 0.090 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 441 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 615 | 0.090 |
Why?
|
| Anticoagulants | 2 | 2016 | 4812 | 0.090 |
Why?
|
| Women's Health Services | 1 | 2010 | 88 | 0.090 |
Why?
|
| North America | 1 | 2013 | 1276 | 0.090 |
Why?
|
| Cytidine Deaminase | 1 | 2012 | 243 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 719 | 0.090 |
Why?
|
| Cytarabine | 1 | 2012 | 698 | 0.080 |
Why?
|
| Hematopoietic System | 1 | 2010 | 110 | 0.080 |
Why?
|
| Stomach | 1 | 2014 | 696 | 0.080 |
Why?
|
| Janus Kinase 2 | 1 | 2013 | 560 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1994 | 2748 | 0.080 |
Why?
|
| Telomerase | 1 | 2014 | 745 | 0.080 |
Why?
|
| Fanconi Anemia Complementation Group C Protein | 1 | 2009 | 21 | 0.080 |
Why?
|
| Feasibility Studies | 1 | 2020 | 5247 | 0.080 |
Why?
|
| Interinstitutional Relations | 1 | 2010 | 236 | 0.080 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 1188 | 0.080 |
Why?
|
| X-Ray Microtomography | 1 | 2011 | 456 | 0.080 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2010 | 181 | 0.080 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2012 | 662 | 0.080 |
Why?
|
| Neoplasm Transplantation | 2 | 2016 | 2016 | 0.080 |
Why?
|
| Cytoplasm | 1 | 2013 | 1510 | 0.080 |
Why?
|
| Fluorouracil | 1 | 2014 | 1642 | 0.080 |
Why?
|
| Interferon-alpha | 1 | 2013 | 921 | 0.080 |
Why?
|
| Cell Survival | 3 | 2016 | 5791 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1704 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 1762 | 0.080 |
Why?
|
| DNA, Complementary | 2 | 2014 | 1991 | 0.080 |
Why?
|
| DNA, Neoplasm | 1 | 1994 | 1745 | 0.080 |
Why?
|
| Female | 17 | 2024 | 392705 | 0.080 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 4807 | 0.080 |
Why?
|
| Mesonephros | 1 | 2007 | 42 | 0.080 |
Why?
|
| Terminal Repeat Sequences | 1 | 2008 | 70 | 0.080 |
Why?
|
| Oncogenes | 1 | 1994 | 1222 | 0.080 |
Why?
|
| Esophagus | 1 | 2014 | 1033 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 1756 | 0.070 |
Why?
|
| Yolk Sac | 1 | 2007 | 79 | 0.070 |
Why?
|
| alpha-Synuclein | 1 | 2014 | 750 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2013 | 1974 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 3 | 2015 | 5790 | 0.070 |
Why?
|
| Mitomycin | 1 | 2008 | 263 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2020 | 3537 | 0.070 |
Why?
|
| Newcastle disease virus | 1 | 2006 | 21 | 0.070 |
Why?
|
| Mast Cells | 1 | 2014 | 1392 | 0.070 |
Why?
|
| Graft Survival | 2 | 2009 | 3820 | 0.070 |
Why?
|
| Opportunistic Infections | 1 | 2010 | 376 | 0.070 |
Why?
|
| Bibliometrics | 1 | 2010 | 352 | 0.070 |
Why?
|
| RNA, Messenger | 3 | 2011 | 12794 | 0.070 |
Why?
|
| Thiazoles | 1 | 2014 | 1517 | 0.070 |
Why?
|
| Poxviridae | 1 | 2006 | 37 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3792 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2009 | 585 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2004 | 2898 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2014 | 16990 | 0.070 |
Why?
|
| Investigational New Drug Application | 1 | 2005 | 5 | 0.070 |
Why?
|
| Treatment Outcome | 4 | 2024 | 64685 | 0.070 |
Why?
|
| Stromal Cells | 1 | 2011 | 1330 | 0.070 |
Why?
|
| DNA Probes | 1 | 2007 | 541 | 0.070 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2005 | 201 | 0.060 |
Why?
|
| Deficiency Diseases | 1 | 2006 | 74 | 0.060 |
Why?
|
| Phagocytosis | 1 | 2011 | 1528 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 2012 | 1768 | 0.060 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2011 | 1115 | 0.060 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2005 | 297 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2011 | 8321 | 0.060 |
Why?
|
| Leukemia Virus, Murine | 1 | 2005 | 94 | 0.060 |
Why?
|
| Dogs | 2 | 2008 | 3839 | 0.060 |
Why?
|
| Tablets | 1 | 2005 | 148 | 0.060 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2007 | 326 | 0.060 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2006 | 168 | 0.060 |
Why?
|
| Drug Stability | 1 | 2005 | 291 | 0.060 |
Why?
|
| Young Adult | 3 | 2020 | 59260 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2018 | 10766 | 0.060 |
Why?
|
| Serotyping | 1 | 2005 | 325 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2020 | 2932 | 0.060 |
Why?
|
| Receptors, Interleukin | 1 | 2006 | 243 | 0.060 |
Why?
|
| Ohio | 1 | 2005 | 322 | 0.060 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1699 | 0.060 |
Why?
|
| Mice, Mutant Strains | 2 | 2010 | 1749 | 0.060 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2014 | 1551 | 0.060 |
Why?
|
| Erythrocyte Membrane | 1 | 2006 | 439 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 1994 | 2448 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 1406 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2014 | 2571 | 0.060 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2005 | 274 | 0.060 |
Why?
|
| Genetic Complementation Test | 1 | 2005 | 555 | 0.060 |
Why?
|
| Group Processes | 1 | 2006 | 228 | 0.060 |
Why?
|
| Pituitary Gland | 1 | 2007 | 635 | 0.060 |
Why?
|
| Research Design | 3 | 2016 | 6180 | 0.060 |
Why?
|
| Gene Deletion | 1 | 2012 | 2665 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2006 | 451 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 2917 | 0.060 |
Why?
|
| Leukemia, Myeloid | 1 | 2007 | 694 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4576 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2013 | 3687 | 0.060 |
Why?
|
| Mice, Inbred C3H | 3 | 1991 | 915 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 6312 | 0.060 |
Why?
|
| Administration, Intranasal | 1 | 2005 | 477 | 0.060 |
Why?
|
| Graft vs Host Disease | 1 | 2016 | 3029 | 0.060 |
Why?
|
| Organizational Objectives | 1 | 2005 | 426 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 3713 | 0.050 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2005 | 439 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3113 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2012 | 2910 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2011 | 1609 | 0.050 |
Why?
|
| Primates | 1 | 2005 | 523 | 0.050 |
Why?
|
| Aerosols | 1 | 2005 | 635 | 0.050 |
Why?
|
| Antigens, CD | 1 | 1993 | 4001 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2007 | 721 | 0.050 |
Why?
|
| Simplexvirus | 1 | 2006 | 803 | 0.050 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2022 | 27 | 0.050 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 2 | 2018 | 263 | 0.050 |
Why?
|
| Gene Expression Regulation | 5 | 2006 | 11904 | 0.050 |
Why?
|
| beta-Globins | 1 | 2022 | 111 | 0.050 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2003 | 562 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2010 | 1204 | 0.050 |
Why?
|
| DNA Damage | 1 | 2012 | 2449 | 0.050 |
Why?
|
| Europe | 1 | 2009 | 3420 | 0.050 |
Why?
|
| Heterozygote | 2 | 2022 | 2787 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1986 | 604 | 0.050 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2005 | 452 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3246 | 0.050 |
Why?
|
| Diffusion of Innovation | 1 | 2005 | 728 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 20100 | 0.040 |
Why?
|
| Cytokines | 2 | 2021 | 7396 | 0.040 |
Why?
|
| Time Factors | 5 | 2011 | 39969 | 0.040 |
Why?
|
| Introns | 1 | 2003 | 981 | 0.040 |
Why?
|
| Skin | 1 | 2014 | 4484 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 2735 | 0.040 |
Why?
|
| Clone Cells | 1 | 2023 | 1659 | 0.040 |
Why?
|
| Liver | 2 | 2007 | 7528 | 0.040 |
Why?
|
| Forecasting | 1 | 2009 | 2928 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2005 | 2065 | 0.040 |
Why?
|
| Neoplasm Proteins | 2 | 2016 | 3617 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9420 | 0.040 |
Why?
|
| Survival Rate | 2 | 2011 | 12723 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17904 | 0.040 |
Why?
|
| Germ Cells | 1 | 2003 | 634 | 0.040 |
Why?
|
| Program Development | 1 | 2005 | 1297 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2019 | 13446 | 0.040 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2003 | 1062 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2020 | 4281 | 0.040 |
Why?
|
| Internet | 2 | 2016 | 3093 | 0.040 |
Why?
|
| Adult | 4 | 2020 | 221210 | 0.040 |
Why?
|
| Adrenal Insufficiency | 1 | 2020 | 194 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4415 | 0.040 |
Why?
|
| Caspase 8 | 1 | 2018 | 190 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 36426 | 0.040 |
Why?
|
| INDEL Mutation | 1 | 2019 | 266 | 0.040 |
Why?
|
| Brain | 1 | 2024 | 27121 | 0.040 |
Why?
|
| Benzylamines | 1 | 2018 | 247 | 0.040 |
Why?
|
| Boston | 1 | 2010 | 9327 | 0.040 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2018 | 140 | 0.040 |
Why?
|
| Moloney murine leukemia virus | 2 | 1987 | 109 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2005 | 1664 | 0.040 |
Why?
|
| Cloning, Molecular | 3 | 1994 | 4174 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2022 | 26202 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2018 | 695 | 0.030 |
Why?
|
| Phosphoglycerate Kinase | 2 | 1993 | 66 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 1994 | 17635 | 0.030 |
Why?
|
| Phylogeny | 1 | 2023 | 2811 | 0.030 |
Why?
|
| Leukemia, Experimental | 1 | 2016 | 225 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2016 | 364 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 413 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 1994 | 1545 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2004 | 4125 | 0.030 |
Why?
|
| Social Participation | 1 | 2016 | 183 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2016 | 352 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 2016 | 472 | 0.030 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 226 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2019 | 1363 | 0.030 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 1993 | 98 | 0.030 |
Why?
|
| Superoxides | 1 | 1995 | 387 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2016 | 712 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2016 | 368 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 1869 | 0.030 |
Why?
|
| A Kinase Anchor Proteins | 1 | 1994 | 57 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2005 | 3066 | 0.030 |
Why?
|
| Piperazines | 2 | 2016 | 2523 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1994 | 777 | 0.030 |
Why?
|
| Calibration | 1 | 2015 | 818 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 1994 | 293 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1987 | 7593 | 0.030 |
Why?
|
| Models, Biological | 1 | 2009 | 9469 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1459 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2008 | 2457 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2008 | 3763 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1994 | 1085 | 0.030 |
Why?
|
| Microfilament Proteins | 2 | 2008 | 1134 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2007 | 5305 | 0.020 |
Why?
|
| Proviruses | 1 | 1993 | 313 | 0.020 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 698 | 0.020 |
Why?
|
| Helper Viruses | 1 | 1991 | 40 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 802 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2014 | 582 | 0.020 |
Why?
|
| Random Allocation | 1 | 2016 | 2395 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2016 | 1416 | 0.020 |
Why?
|
| Phenylalanine | 1 | 2013 | 366 | 0.020 |
Why?
|
| Valine | 1 | 2013 | 408 | 0.020 |
Why?
|
| Nitrophenols | 1 | 2011 | 169 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2013 | 491 | 0.020 |
Why?
|
| Membrane Microdomains | 1 | 2012 | 206 | 0.020 |
Why?
|
| Gene Library | 1 | 1993 | 1059 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2011 | 410 | 0.020 |
Why?
|
| Codon, Terminator | 1 | 2010 | 124 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 1989 | 352 | 0.020 |
Why?
|
| DNA Primers | 1 | 1993 | 2820 | 0.020 |
Why?
|
| Muscles | 1 | 1994 | 1576 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 7391 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2010 | 386 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1994 | 1173 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 1739 | 0.020 |
Why?
|
| Pituitary Hormones, Anterior | 1 | 2007 | 56 | 0.020 |
Why?
|
| Lymphopoiesis | 1 | 2008 | 133 | 0.020 |
Why?
|
| Biological Transport | 1 | 2012 | 2091 | 0.020 |
Why?
|
| Mice, Nude | 1 | 1994 | 3614 | 0.020 |
Why?
|
| Dwarfism, Pituitary | 1 | 2007 | 39 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 1993 | 2329 | 0.020 |
Why?
|
| Age Determination by Skeleton | 1 | 2007 | 126 | 0.020 |
Why?
|
| Reticulocytosis | 1 | 2006 | 10 | 0.020 |
Why?
|
| Puberty, Delayed | 1 | 2007 | 121 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2011 | 1007 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2010 | 517 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2007 | 208 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 11742 | 0.020 |
Why?
|
| Microtubules | 1 | 2012 | 1074 | 0.020 |
Why?
|
| Spectrin | 1 | 2006 | 170 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2016 | 3551 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2012 | 2510 | 0.020 |
Why?
|
| Proteome | 1 | 2016 | 1862 | 0.020 |
Why?
|
| Telomere | 1 | 2012 | 943 | 0.020 |
Why?
|
| Cephalometry | 1 | 2007 | 382 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2010 | 1494 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2007 | 618 | 0.020 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 416 | 0.020 |
Why?
|
| Hypopituitarism | 1 | 2007 | 250 | 0.020 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2006 | 233 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 1968 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2008 | 838 | 0.020 |
Why?
|
| Thyroid Hormones | 1 | 2007 | 404 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2811 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3575 | 0.010 |
Why?
|
| DNA | 2 | 1989 | 7213 | 0.010 |
Why?
|
| Virion | 1 | 1986 | 422 | 0.010 |
Why?
|
| Carmustine | 1 | 2003 | 138 | 0.010 |
Why?
|
| Immune System Diseases | 1 | 1986 | 256 | 0.010 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2007 | 702 | 0.010 |
Why?
|
| Microcephaly | 1 | 2007 | 425 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2007 | 575 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1991 | 1250 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2011 | 2386 | 0.010 |
Why?
|
| Alleles | 2 | 2010 | 6864 | 0.010 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2005 | 416 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 1600 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 2007 | 642 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 1120 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2004 | 23996 | 0.010 |
Why?
|
| Organ Size | 1 | 2007 | 2254 | 0.010 |
Why?
|
| Recurrence | 1 | 2014 | 8466 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2016 | 12341 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2011 | 1979 | 0.010 |
Why?
|
| Plasmids | 1 | 1987 | 2269 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2008 | 1889 | 0.010 |
Why?
|
| Cell Division | 1 | 2008 | 4465 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 2003 | 594 | 0.010 |
Why?
|
| Body Height | 1 | 2007 | 1570 | 0.010 |
Why?
|
| Myocardium | 1 | 1994 | 4725 | 0.010 |
Why?
|
| Macrophages | 2 | 2011 | 5767 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 2057 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2007 | 1935 | 0.010 |
Why?
|
| Risk Factors | 2 | 2003 | 74213 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2007 | 1819 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2008 | 2547 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 10212 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 8554 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 13642 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1986 | 2612 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 2112 | 0.010 |
Why?
|
| Anemia | 1 | 2006 | 1509 | 0.010 |
Why?
|
| Immunity | 1 | 2003 | 996 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2003 | 1590 | 0.010 |
Why?
|
| Acute Disease | 1 | 2007 | 7237 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1986 | 3442 | 0.010 |
Why?
|
| Cytochrome b Group | 1 | 1995 | 59 | 0.010 |
Why?
|
| Lung | 1 | 1994 | 10002 | 0.010 |
Why?
|
| Quality of Life | 1 | 2016 | 13367 | 0.010 |
Why?
|
| Lung Diseases, Fungal | 1 | 1995 | 126 | 0.010 |
Why?
|
| Proteins | 1 | 2008 | 6032 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 1995 | 157 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2007 | 3964 | 0.010 |
Why?
|
| Aspergillosis | 1 | 1995 | 242 | 0.010 |
Why?
|
| Peritonitis | 1 | 1995 | 368 | 0.010 |
Why?
|
| X Chromosome | 1 | 1995 | 816 | 0.010 |
Why?
|
| Simian virus 40 | 1 | 1991 | 291 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 22176 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1995 | 2341 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 20568 | 0.000 |
Why?
|
| Prostatic Neoplasms | 1 | 1991 | 11122 | 0.000 |
Why?
|
| Staphylococcus aureus | 1 | 1995 | 1457 | 0.000 |
Why?
|
| Cell Transformation, Viral | 1 | 1987 | 526 | 0.000 |
Why?
|
| Staphylococcal Infections | 1 | 1995 | 1407 | 0.000 |
Why?
|
| Middle Aged | 1 | 2016 | 220921 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1987 | 6534 | 0.000 |
Why?
|